Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkers

Ended Awarded Last action

Contract number
HHSN261201500018I
Awardee
Awarding agency
Task orders
9 $5,504,145 obligated

Award facts

Combined order value
$5,504,145 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 18% used
$29,800,000.00
Maximum order
$19,800,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Targeting the RXR pathway for the prevention of triple-negative breast cancer HHSN2612015000181 task order 9 75N91018F00008 National Cancer Institute (NIH) $774,513
Rank ligand inhibition - a potential chemoprevention strategy for women at high genetic risk of breast cancer… 75N91018F00009 National Cancer Institute (NIH) $849,016
Prevention of hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (nash) 75N91018F00007 National Cancer Institute (NIH) $728,679
Targeting the mtor pathway for the prevention of breast cancer HHSN26100006 National Cancer Institute (NIH) $714,124
Targeted casein kinase inhibition as a breast cancer prevention HHSN26100005 National Cancer Institute (NIH) $505,743
Determination of dosing regimens of erlotinib in combination with sulindac for prevention of colorectal cancer while… HHSN26100004 National Cancer Institute (NIH) $979,494
Cancer prevention by alpha enolase vaccination HHSN26100003 National Cancer Institute (NIH) $547,719
Examination of HJC0152 HHSN26100002 National Cancer Institute (NIH) $400,411
Contract orientation and kickoff meeting HHSN26100001 National Cancer Institute (NIH) $4,445

Transactions

Action Obligated Date
Additional Work (new agreement, FAR part 6 applies) 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201500018I?

HHSN261201500018I was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500018I worth?

Orders under HHSN261201500018I have obligated $5,504,145. HHSN261201500018I's own ceiling is $29,800,000. A single order can be worth up to $19,800,000.

How many orders have been placed under contract HHSN261201500018I?

9 orders have been placed under HHSN261201500018I, the latest on September 17, 2018.

Who can order from contract HHSN261201500018I?

HHSN261201500018I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201500018I part of a contract vehicle?

Yes. HHSN261201500018I is part of PREVENT Cancer Program (PREVENT).

Was contract HHSN261201500018I competed?

The extent of competition for HHSN261201500018I was full and open competition. The government received 9 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login